- Home
- OAKU vs FORA Comparison
OAKU vs FORA Comparison
Compare OAKU & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OAKU
- FORA
- Stock Information
- Founded
- OAKU 2022
- FORA 2014
- Country
- OAKU Canada
- FORA United States
- Employees
- OAKU N/A
- FORA N/A
- Industry
- OAKU Blank Checks
- FORA Computer Software: Prepackaged Software
- Sector
- OAKU Finance
- FORA Technology
- Exchange
- OAKU Nasdaq
- FORA Nasdaq
- Market Cap
- OAKU 84.3M
- FORA 63.8M
- IPO Year
- OAKU 2023
- FORA N/A
- Fundamental
- Price
- OAKU $11.20
- FORA $2.10
- Analyst Decision
- OAKU
- FORA Strong Buy
- Analyst Count
- OAKU 0
- FORA 1
- Target Price
- OAKU N/A
- FORA $5.00
- AVG Volume (30 Days)
- OAKU 5.8K
- FORA 14.2K
- Earning Date
- OAKU 01-01-0001
- FORA 11-07-2024
- Dividend Yield
- OAKU N/A
- FORA N/A
- EPS Growth
- OAKU N/A
- FORA N/A
- EPS
- OAKU 0.10
- FORA 0.06
- Revenue
- OAKU N/A
- FORA $20,371,880.00
- Revenue This Year
- OAKU N/A
- FORA N/A
- Revenue Next Year
- OAKU N/A
- FORA $10.64
- P/E Ratio
- OAKU $116.90
- FORA $36.34
- Revenue Growth
- OAKU N/A
- FORA 6.97
- 52 Week Low
- OAKU $10.45
- FORA $2.00
- 52 Week High
- OAKU $11.22
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- OAKU 70.55
- FORA 38.13
- Support Level
- OAKU $10.98
- FORA $2.05
- Resistance Level
- OAKU $11.22
- FORA $2.16
- Average True Range (ATR)
- OAKU 0.00
- FORA 0.05
- MACD
- OAKU -0.00
- FORA 0.00
- Stochastic Oscillator
- OAKU 71.43
- FORA 31.77
About OAKU Oak Woods Acquisition Corporation
Oak Woods Acquisition Corp is a a newly-incorporated blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.